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Abstract: We investigated chronological changes in immunohistochemical phenotyping in the thymus and spleen in Crl:CD rats up to 
the age of about one year. In the thymus, T cells increased markedly from 3 to 4 weeks of age. Proliferating cells also increased mark-
edly at these points. B cells tended towards an increase with age. In the spleen, white pulp increased until 9 weeks of age and remained 
fairly stable thereafter. In the periarteriolar lymphoid sheath and marginal zone, T cells gradually increased until 9 weeks of age and 
became almost flat thereafter. In the lymph follicle, T cells increased with age. B cells tended towards an increase with age in all areas 
of the spleen. It was concluded that development of the thymus was most marked from 3 to 4 weeks of age and that both the thymus and 
spleen had matured by 9 weeks of age. (DOI: 10.1293/tox.25.55; J Toxicol Pathol 2012; 25: 55–61)
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According to Immunotoxicity Studies For Human 
Pharmaceuticals (ICH S8 Guideline Step 5)1, evaluation of 
the potential adverse effects of human pharmaceuticals on 
the immune system should be incorporated into standard 
toxicity studies (STS). Among additional immunotoxic-
ity studies, immunohistochemistry (IHC) of leukocyte 
populations can identify specific cell populations and may 
provide useful clinical biomarkers. IHC can be analyzed 
retrospectively if signs of immunotoxicity are observed in 
STS, and changes in cell types within a specific compart-
ment of lymphoid tissue can be observed2. Marked changes 
in the numbers and proportions of tissue leukocytes (par-
ticularly T cells and B cells) in dogs and cats in the year 
following birth have been reported3–5. Moreover, immune 
function (morphological, cellular and biochemical changes) 
is known to decline with age in humans6, mice7, Fischer 
F344 rats8, beagles9 and cynomolgus monkeys10. For these 
reasons, studies on age differences in the immune system 
are needed for the evaluation of immunotoxicity in neonatal 
or long-term toxicity studies. However, until now, detailed 
investigations of age differences in the immune organs have 
not been performed in any species. Therefore, in the pres-
ent study, we investigated changes in the chronological IHC 
phenotyping of immune cells in the thymus and spleen in 
Crl:CD (SD) rats. This is one of the first studies to report on 
the chronological IHC phenotyping of immune cells in the 
thymus and spleen in SD rats.
Eighty-five  male  and  eighty-three  female  SD  rats 
(Charles River Laboratories Japan, Inc., Shiga, Japan) were 
used in this study. Neonates (38 males and 35 females) born 
to seven dams were evenly allocated to groups aged 1 to 4 
weeks. They were housed with their dams from birth to 3 
weeks and individually after weaning (from 4 weeks). All 
procedures involving animals were approved by the Insti-
tutional Animal Care and Use Committee of Shin Nippon 
Biomedical Laboratories Ltd. and were performed in accor-
dance with standards published by the National Research 
Council (Guide for the Care and Use of Laboratory Ani-
mals, NIH OACU) and the U.S. National Institutes of Health 
policy on humane care and use of laboratory animals.
All rats were anesthetized by an intraperitoneal injec-
tion of sodium pentobarbital (Tokyo Chemical Industry Co., 
Ltd., Tokyo, Japan) solution (6.48 mg/mL, 5 mL/kg) after 
being weighed (Fig. 1) and were then euthanized by exsan-
guination. Animals were necropsied chronologically up to 
the age of about one year (aged 1, 2, 3, 4, 9, 19, 23, 46 and 
57 weeks), weekly from birth to 4 weeks of age and at sub-
sequent points based on the end of the dosing or recovery 
period in repeated-dose toxicity studies. The thymuses and 
spleens from all animals were fixed in 10% neutral buff-
ered formalin. According to ICH S8 Guideline Step 51, his-
topathological changes in the thymus and spleen should be 
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evaluated as indicators of systemic immunotoxicity. The 
thymus and spleen were selected because the former is a 
primary lymphoid organ considered to be consistently sen-
sitive to morphological effects2, and the latter is a second-
ary lymphoid organ. They were incised vertically along the 
center, trimmed, embedded in paraffin and then sectioned. 
Three-micrometer sections were cut from formalin-fixed, 
paraffin-embedded blocks, mounted on positively charged 
glass slides and deparaffinized.
Consecutively cut sections were stained for IHC with 
CD3 (thymocytes, peripheral T lymphocytes and dendritic 
epidermal T cells), CD45RA (B cells among thoracic duct 
lymphocytes, with little labeling in bone marrow and none 
on thymocytes), CD68 (monocytes, macrophages and den-
dritic cells), CD161a (natural killer cell receptor protein 
1a; NKR) and Proliferating Cell Nuclear Antigen (cycling 
cells during the last 5% of the G1 phase and the first 35% 
of the S phase; PCNA). All sections were then treated with 
N-Histofine Simple Stain Rat MAX PO (MULTI) (Nichirei 
Biosciences Inc., Tokyo, Japan). Immunoreactive elements 
were visualized by the DAB+ Liquid System (DAKO Ja-
pan, Kyoto, Japan). The morphometric analysis areas were 
the cortex and medulla of the thymus and the periarteriolar 
lymphoid sheath (PALS), marginal zone (MZ) and lymph 
follicle (LF) of the spleen. An IHC-positive reaction within 
a constant and tone range was assumed, and each IHC-pos-
itive cell (CD3-, CD45RA-, CD68-, NKR- and PCNA-posi-
tive cells expressed as T cells, B cells, macrophages, natural 
killer cells and proliferating cells, respectively, hereafter) 
Fig. 1.  Changes in body weight in male and female SD rats were 
graphed up to about one year of age. Neonates (38 males 
and 35 females) born to seven dams were evenly allocated 
to groups aged 1 to 4 weeks. They were housed with their 
dams from birth to 3 weeks of age and individually after 
weaning (from 4 weeks). White and black bars indicate 
males and females, respectively. N indicates the numbers 
of male and female SD rats. Values (g) are expressed as 
means ± SD.
Fig. 2.  Thymus histology and IHC from 9 weeks of age in male SD 
rats. a: HE stain. b: T cells diffusely locate in the cortex and 
medulla (CD3 IHC stain). c: A few B cells cluster at the cor-
ticomedullary junction (CD45RA IHC stain). d: A few mac-
rophages were diffusely located in the cortex and medulla 
(CD68 IHC stain). e: A few natural killer cells were located 
around the corticomedullary junction (CD161a IHC stain). f: 
Proliferating cells are predominantly located in the cortex 
(PCNA IHC stain). Cortex (C) and medulla (M). Bar = 200 
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was picked up automatically and determined quantitatively 
using computerized image analyses (shown in Figs. 2 and 3) 
and morphometric techniques (Soft Imaging System GmbH, 
Muenster, Germany). The white pulp area and occupancy 
of the spleen were also calculated from these computerized 
image analyses and morphometric techniques. The data on 
T cells, B cells, macrophages, natural killer cells and prolif-
erating cells obtained were compared with data at 9 weeks 
of age. We postulated that the immune system would have 
fully matured by that age because SD rats of that age, cor-
responding to an adolescent human and an age at which the 
nervous and reproductive systems have matured11,12, have 
been widely used in STS. Data were expressed as means 
± standard deviation (S.D.). Percentages against the preap-
plication values were analyzed for homogeneity of vari-
ance by the F-test. When the variances were homogenous, 
a Student’s t-test was performed. When the variances were 
heterogeneous, the Aspin-Welch test was performed. These 
statistical analyses were conducted using MUSCOT statis-
tical analysis software (Yukms Co., Ltd., Tokyo, Japan) at 
significance levels of 5% and 1%.
Figure 4 shows changes in each cell in the cortex and 
medulla of the thymus in male and female SD rats. In the 
thymus, the number of T cells, B cells, macrophages, natu-
ral killer cells and proliferating cells was generally greater 
in the cortex than in the medulla through all age groups. 
T cells in the thymus increased until 4 weeks of age, and 
in particular, a marked increase of approximately three- to 
fourfold was noted from 3 to 4 weeks of age. T cells in the 
cortex markedly decreased from 4 to 9 weeks of age and 
gradually decreased thereafter. Atrophy of the cortex was 
observed in 1 of 5 males at 23 weeks of age and in almost all 
males and females at 46 and 57 weeks of age by HE staining. 
In the medulla, T cells decreased from 4 to 9 weeks of age, 
remained fairly stable until 23 weeks of age and decreased 
thereafter. The degree of the decrease after 4 weeks of age 
was less than that in the cortex. B cells in the thymus tended 
towards an increase with age. The degree of the increase at 
57 weeks of age was greater in the cortex than in the medul-
la. Macrophages in the thymus increased from 3 to 4 weeks 
of age, remained fairly stable until 19 weeks of age and de-
creased thereafter. There was no marked difference in pat-
terns between the cortex and medulla. Natural killer cells 
in the cortex showed high values triphasically at 1, 19 and 
57 weeks of age. In the medulla, they increased from 3 or 
4 weeks of age to 23 weeks of age and gradually decreased 
thereafter. Proliferating cells in the thymus increased until 
4 weeks of age, decreased thereafter and showed a similar 
pattern to the number of T cells in the cortex.
In the spleen, the white pulp occupancy and area in-
creased until 9 weeks of age and remained fairly stable 
thereafter (Fig. 5). Figure 6 shows changes in each cell in the 
PALS, MZ and LF of the spleen in male and female SD rats. 
At 4 weeks of age, the number of B cells, macrophages and 
proliferating cells in the MZ were much lower than the num-
bers at any other week. These results were considered to be 
due to the following: the LF was not apparent until 3 weeks 
Fig. 3.  Spleen histology and IHC from 9 weeks of age in male SD 
rats. a: HE stain. b: T cells are predominantly located in P 
and diffusely located in the red pulp (CD3 IHC stain). c: B 
cells are predominantly located in L and diffusely located 
in M (CD45RA IHC stain). A few macrophages are located 
approximately equally in all areas of the spleen (CD68 IHC 
stain). e: A few natural killer cells are located approximately 
equally in all areas of the spleen (CD161a IHC stain). f: Pro-
liferating cells are predominantly located in P (PCNA IHC 
stain). Periarteriolar lymphoid sheath (P), lymph follicle (L) 
and marginal zone (M). Bar = 200 μm.IHC Study in Thymus and Spleen in SD Rats 58
Fig. 4.  Changes in T cells, B cells, macrophages, natural killer cells and proliferating cells in the cortex and medulla of the thymus of male 
and female SD rats. The number of each cell was graphed up to about one year of age. Cortex (left) and medulla (right). White and 
black bars indicate males and females, respectively. Values (cells) are expressed as means ± SD. * and **: Asterisks indicate signifi-
cant differences from the mean at 9 weeks of age (p < 0.05 and p < 0.01, respectively).Kodama, Okazaki, Sato et al. 59
of age but was clearly evident in the MZ from 4 weeks of 
age; therefore, the LF was separated from the MZ and ad-
opted as the morphometric area from 4 weeks of age. Large 
numbers of T cells were noted in the spleen in this order: the 
PALS, MZ and then LF. In the PALS and MZ, they gradu-
ally increased until 9 weeks of age and became almost flat 
thereafter. In the LF, they increased with age. B cells tended 
towards an increase with age in all areas of the spleen, and 
the largest number was found in the LF. The number of mac-
rophages was approximately equal in all areas of the spleen 
and remained stable through all age groups. The smallest 
number of natural killer cells was noted in the PALS of the 
spleen, increasing at 9 weeks of age and becoming almost 
flat thereafter. In the MZ and LF, they increased biphasi-
cally at 19 and 57 weeks of age. Proliferating cells tended 
towards an increase until 19 weeks of age and gradually 
decreased thereafter in all areas of the spleen. The largest 
number was found in the LF.
The present study is one of the first to have investigated 
chronological changes in the IHC phenotyping of immune 
cells in the thymus and spleen in male and female SD rats 
up to the age of about one year. Moreover, we revealed dif-
ferences in the characteristics of thymic and splenic devel-
opment. In the thymus, T cells comprised the majority of 
the cellular components in the cortex and medulla, and their 
number increased markedly from 3 to 4 weeks of age (ap-
proximately 3 to 4-fold). Proliferating cells also increased 
markedly at these points. In the present study, juveniles 
routinely suckled until 3 weeks of age and were weaned 
thereafter. Neonates have a T-helper (Th) 2-dominant im-
mune system derived from maternal immunity. In juveniles, 
exogenous antigens are generally known to be kept at a low 
level by the mother-infant immune system in two ways: an-
tigens in the blood are neutralized by transplacentally ac-
quired IgG, and those in the digestive tract are neutralized 
by IgA acquired from milk. After weaning, they actively 
ingest food, and exposure to exogenous antigens naturally 
increases4,5. It has been reported13 that intestinal microbiota 
is postulated to be a posterior immunomodulator that is an 
inverse Th2-dominant immune system in juveniles derived 
from maternal immunity. It was considered, therefore, that 
active food ingestion increased the exposure of juveniles to 
exogenous antigens and activated the intestinal microbiota. 
Activated microbiota modulated the Th1-dominant immune 
system (ingestant desensitization13) and resulted in differ-
entiation and maturation of immature T cells. Weaning is 
considered to trigger marked T cell proliferation.
In the spleen, the white pulp area and occupancy in-
creased until 9 weeks of age and remained fairly stable 
thereafter. Moreover, the IHC phenotyping showed that the 
number of cells composing each area in the spleen (PALS, 
MZ or LF) increased markedly from 4 to 9 weeks of age. 
However, there was a slight increase in accompanying cell 
proliferation at this point. These results were considered to 
indicate that mature T cells released from the thymus con-
tributed to the increase in the number of T cells in the PALS 
of the spleen. T cells in the thymus tended to regress after 9 
weeks of age; in contrast, their number in each area of the 
spleen was maintained. It was considered that an age-related 
decline was unlikely to have occurred in the secondary lym-
phoid organs because of an influx from the other lymphoid 
organs at 4 weeks of age and proliferation in the PALS14. 
B cells tended to increase with age in the spleen as well as 
the thymus, which is consistent with age-related changes in 
humans14,15. It has been reported that T cell function and 
recruiting of naïve T cells decline with age15. Age-related 
enhancement of humoral immunity and the nonspecific im-
mune response may be compensatory reactions to declined 
specific cellular immunity.
From the above, it was concluded that development of 
the thymus, the primary lymphoid organ, was most marked 
from 3 to 4 weeks of age, earlier than the spleen, the second-
ary lymphoid organ, and that both the thymus and spleen had 
matured by 9 weeks of age. It was suggested that weaning, 
an external factor, was a possible trigger for the initiation 
of development of the thymus from 3 to 4 weeks of age and 
that mature T cells released from the thymus and B cell pro-
liferation in the LF contributed to maturation of the spleen 
Fig. 5.  White pulp occupancy (%) and white pulp area (mm2) in 
the spleen were graphed up to about one year of age in 
male and female SD rats. White and black bars indicate 
males and females, respectively. Values are expressed as 
means ± SD. * and **: Asterisks indicate significant dif-
ferences from the mean at 9 weeks of age (p < 0.05 and p 
< 0.01, respectively).IHC Study in Thymus and Spleen in SD Rats 60
Fig. 6.  Changes in T cells, B cells, macrophages, natural killer cells and proliferating cells in the periarteriolar lymphoid sheath (PALS), mar-
ginal zone (MZ) and lymph follicle (LF) of the spleen of male and female SD rats. The number of each cell was graphed up to about one 
year of age. At 4 weeks of age, the numbers of B cells, macrophages and proliferating cells in the MZ were much lower than those at any 
other week. These results were considered to be due to the following: the LF was not apparent until 3 weeks of age but was clearly evident 
in the MZ from 4 weeks of age; therefore, the LF was separated from the MZ and adopted as the morphometric area from 4 weeks of age. 
PALS (left), MZ (middle), and LF (right). White and black bars indicate males and females, respectively. Values (cells) are expressed as 
means ± SD. * and **: Asterisks indicate significant differences from the mean at 9 weeks of age (p < 0.05 and p < 0.01, respectively).Kodama, Okazaki, Sato et al. 61
by 9 weeks of age. Moreover, it was concluded from these 
findings that when evaluating immunotoxicity in toxicity 
studies, in addition to the age and treatment duration, the 
weaning period must be also considered when distinguish-
ing between the transient effects of immune modulation and 
the persistent consequences of developmental toxicity.
Acknowledgment: The authors are grateful to Medical 
English Service, K. K. for its review of the manuscript and 
advice.
References
  1.  Immunotoxicity Studies For Human Pharmaceuticals. ICH 
S8 Guideline Step 5.
  2.  Harleman JH. Approaches to the identification and record-
ing of findings in the lymphoreticular organs indicative for 
immunotoxicity in regulatory type toxicity studies. Toxi-
cology. 142: 213–219. 2000. [Medline]  [CrossRef]
  3.  Day MJ. Immune system development in the dog and cat. J 
Comp Pathol. 137: S10–S15. 2007. [Medline]  [CrossRef]
  4. Morein B, Abusugra I, and Blomqvist G. Immunity in 
neonates. Vet Immunol Immunopathol. 87: 207–213. 2002. 
[Medline]  [CrossRef]
  5.  Morein B, Blomqvist G, and Hu K. Immune responsiveness 
in the neonatal period. J Comp Pathol. 137: S27–S31. 2007. 
[Medline]  [CrossRef]
  6.  Singh J, and Singh AK. Age-related changes in human thy-
mus. Clin Exp Immunol. 37: 507–511. 1979. [Medline]
  7. Schwander R, Hess MW, Keller HU, and Cottier H. The 
post-natal development of lymph nodes in mice. Immunobi-
ology. 157: 425–436. 1980. [Medline]  [CrossRef]
  8. Cheung HT, and Nadakavukaren MJ. Age-dependent 
changes in the cellularity and ultrastructure of the spleen 
of Fischer F344 rats. Mech Ageing Dev. 22: 23–33. 1983. 
[Medline]  [CrossRef]
  9.  Yang TJ, and Gawlak SL. Lymphoid organ weights and or-
gan: body weight ratios of growing beagles. Lab Anim. 23: 
143–146. 1989. [Medline]  [CrossRef]
  10.  Spoor MS, Radi ZA, and Dunstan RW. Characterization of 
age- and gender-related changes in the spleen and thymus 
from control cynomolgus macaques used in toxicity stud-
ies. Toxicol Pathol. 36: 695–704. 2008. [Medline]  [Cross-
Ref]
  11. Baldrick P. Developing drugs for pediatric use: a role for 
juvenile animal studies? Regul Toxicol Pharmacol. 39: 381–
389. 2004. [Medline]  [CrossRef]
  12.  FDA 2006. Guidance for industry nonclinical safety evalu-
ation of pediatric drug products. Document available at 
http://www.fda.gov/cder/guidance/index.htm.
  13.  Ji GE. Probiotics in primary prevention of atopic dermatitis. 
Forum Nutr. 61: 117–128. 2009. [Medline]  [CrossRef]
  14.  Gruver AL, Hudson LL, and Sempowski GD. Immunose-
nescence of ageing. J Pathol. 211: 144–156. 2007. [Medline]  
[CrossRef]
  15. Bhan AK, Reinherz EL, Poppema S, McCluskey RT, and 
Schlossman SF. Location of T cell and major histocompat-
ible antigens in the human thymus. J Exp Med. 152: 771–
782. 1980. [Medline]  [CrossRef]